|
Nephrology Hypertension Journal Club Role of light chain clearance in the recovery of renal function in multiple myeloma: another point of view July 12 2024 |
07/12/2024 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club Dialysate Sodium Lowering in Maintenance Hemodialysis July 19 2024 |
07/19/2024 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club Adherence to Plant Based Diets and Risk of CKD Progression and All Cause Mortality Findings From the Chronic Renal Insufficiency Cohort CRIC Study July 26 2024 |
07/26/2024 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club A Randomized Trial of Intravenous Amino Acids for Kidney Protection August 2nd 2024 |
08/02/2024 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients with Type 2 Diabetes August 16th 2024 |
08/16/2024 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club Preventive Pharmacological Therapy and Risk of Recurrent Urinary Stone Disease August 23 2024 |
08/23/2024 - 7:30am to 8:30am |
|
CANCELLED Nephrology Hypertension Journal Club Sodium F18-FDG PET Imaging as a diagnostic tool for immune checkpoint inhibitor associated acute kidney injury August 30 2024 |
08/30/2024 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club Autoantibodies Targeting Nephrin in Podocystopathies September 13 2024 |
09/13/2024 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club GLP-1RA vs DPP-4i Use and Rates of Hyperkalemia and RAS Blockade Discontinuation in Type 2 Diabetes September 20, 2024 |
09/20/2024 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club: A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection |
09/27/2024 - 7:30am to 8:30am |
Facebook
X
LinkedIn
Forward